ozempic and other glp 1 drugs Off-Label for Type Diabetes GLP-1 Medications for Weight Loss:

Supports cognitive performance, memory, and mental clarity

Control mice showed significant hepatic steatosis after 1 week of MCDD feeding, whereas mice with GSTM2 overexpression showed this effect at 4 weeks

The bioavailability through the nose is lower than through an injection, so the dose has to be larger

Patients should be counseled to report severe abdominal pain immediately Gallbladder disease : Increased risk of cholelithiasis and cholecystitis, likely related to rapid weight loss Hypoglycemia : Risk is low when used alone but increases when combined with insulin or sulfonylureas Thyroid C-cell tumors : Based on rodent studies, these agents carry a boxed warning and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Acute kidney injury : Can occur, particularly with dehydration from gastrointestinal side effects Diabetic retinopathy complications : Semaglutide may worsen diabetic retinopathy in patients with diabetes, particularly with rapid improvement in glucose control Severe gastrointestinal disease : Use with caution in patients with gastroparesis or severe gastrointestinal disease